Genetically modified human umbilical cord blood cells as a promising strategy for treatment of spinal cord injury

被引：1
|
作者：
Yana O.Mukhamedshina [1 ]
Albert A.Rizvanov [1 ]
机构：
[1] Kazan(Volga Region) Federal University
来源：
Neural Regeneration Research | 2016年 / 11卷 / 09期
基金：
俄罗斯基础研究基金会;
关键词：
gene; cell; VEGF; GDNF; Genetically modified human umbilical cord blood cells as a promising strategy for treatment of spinal cord injury; SCI;
D O I：
暂无
中图分类号：
R651.2 [脊髓];
学科分类号：
1002 ; 100210 ;
摘要：
Spinal cord injury(SCI)continues to be a pressing health and social problem.The injury leads to neuronal and glial cell death accompanied by degeneration of nerve fibers.There are currently no particularly effective treatments.SCI causes profound disability of people affected and has attracted increased attention in the international field of neuroregeneration.For the past two decades,
引用
收藏
页码：1420 / 1421
页数：2
相关论文
共 50 条
  • [41] VEGF165 gene-modified human umbilical cord blood mesenchymal stem cells protect against acute liver failure in rats
    Chen, Haiou
    Tang, Shigang
    Liao, Jinmao
    Liu, Meng
    Lin, Yihe
    JOURNAL OF GENE MEDICINE, 2021, 23 (10)
  • [42] Factors inducing human umbilical cord blood-derived mesenchymal stem cells to differentiate into neuron-like cells
    Nawei Zhang
    NeuralRegenerationResearch, 2006, (06) : 545 - 548
  • [43] Direct conversion of human umbilical cord mesenchymal stem cells into retinal pigment epithelial cells for treatment of retinal degeneration
    Zhu, Xiaoman
    Chen, Zhiyang
    Wang, Li
    Ou, Qingjian
    Feng, Zhong
    Xiao, Honglei
    Shen, Qi
    Li, Yingao
    Jin, Caixia
    Xu, Jing-Ying
    Gao, Furong
    Wang, Juan
    Zhang, Jingfa
    Zhang, Jieping
    Xu, Zhiguo
    Xu, Guo-Tong
    Lu, Lixia
    Tian, Haibin
    CELL DEATH & DISEASE, 2022, 13 (09)
  • [44] The human umbilical cord stem cells improve the viability of OA degenerated chondrocytes
    Wang, Hao
    Yan, Xu
    Jiang, Yuxin
    Wang, Zheng
    Li, Yufei
    Shao, Qingdong
    MOLECULAR MEDICINE REPORTS, 2018, 17 (03) : 4474 - 4482
  • [45] Old drugs,new tricks:the strategy for new drug development in spinal cord injury
    Yu-long Zhou
    Jian Xiao
    NeuralRegenerationResearch, 2015, 10 (12) : 1972 - 1975
  • [46] Reduced reciprocal inhibition during assisted stepping in human spinal cord injury
    Knikou, Maria
    Mummidisetty, Chaithanya K.
    EXPERIMENTAL NEUROLOGY, 2011, 231 (01) : 104 - 112
  • [47] Coadministration of the Human Umbilical Cord Matrix-Derived Mesenchymal Cells and Aspirin Alters Postischemic Brain Injury in Rats
    Ara, Ali Shams
    Sheibani, Vahid
    Esmaeilpour, Khadije
    Eslaminejad, Touba
    Nematollahi-Mahani, Seyed N.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2015, 24 (09) : 2005 - 2016
  • [48] Role of Aldynoglia Cells in Neuroinflammatory and Neuroimmune Responses after Spinal Cord Injury
    Buzoianu-Anguiano, Vinnitsa
    Torres-Llacsa, Mabel
    Doncel-Perez, Ernesto
    CELLS, 2021, 10 (10)
  • [49] Modification of autophagy-lysosomal pathway as a neuroprotective treatment for spinal cord injury
    Marta M.Lipinski
    Junfang Wu
    Neural Regeneration Research, 2015, 10 (06) : 892 - 893
  • [50] Transcutaneous electrical nerve stimulation for treatment of spinal cord injury neuropathic pain
    Norrbrink, Cecilia
    JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT, 2009, 46 (01) : 85 - 93
12345